Figure 3. Use of> CRISPR/Cas9 gene editing to examine the tumorigenic consequences of modifying specific genes in human cells.

In this methodology, the test cells are exposed to CRISPR/Cas9 reagents and then transplanted into immunodeficient mice as in Fig. 2.